The vascular effects of topical and intravenous α2-adrenoceptor agonist clonidine on canine pial microcirculation

Anesthesia and Analgesia

Volumn 86, Issue 4, 1998, Pages 766-772

  Ishiyama, Tadahiko ^a,b   Dohi, Shuji ^a   Iida, Hiroki ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; GLIBENCLAMIDE; GLUCOSE; PENTOBARBITAL; POTASSIUM CHANNEL; POTASSIUM ION; YOHIMBINE;

ANIMAL EXPERIMENT; ARTICLE; BRADYCARDIA; BRAIN MICROCIRCULATION; CONTROLLED STUDY; DOG; DOSE RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PIA ARTERY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION; VASOCONSTRICTION;

ADJUVANTS, ANESTHESIA; ADMINISTRATION, TOPICAL; ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ARTERIES; BLOOD GLUCOSE; CEREBROVASCULAR CIRCULATION; CLONIDINE; CRANIOTOMY; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYBURIDE; HEART RATE; INJECTIONS, INTRAVENOUS; MICROCIRCULATION; PENTOBARBITAL; PIA MATER; POTASSIUM; POTASSIUM CHANNEL BLOCKERS; RECEPTORS, ADRENERGIC, ALPHA-2; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS; VEINS; YOHIMBINE;

EID: 0031967489     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199804000-00017     Document Type: Article

References (34)

1. 2-adrenoceptors in pial arteries of anesthetized newborn pigs. Dev Pharmacol Ther 1987;10:36-46.
2. Hayashi S, Park MK, Kuehl TJ. Postsynaptic alpha adrenoceptors in baboon cerebral and mesenteric arteries. J Pharmacol Exp Ther 1985;235:113-21.
3. Crosby G, Russo MA, Szabo MD, Davies KR. Subarachnoid clonidine reduces spinal cord blood flow and glucose utilization in conscious rats. Anesthesiology 1990;73:1179-85.
4. Tsukahara T, Taniguchi T, Usui H, et al. Sympathetic denervation and alpha adrenoceptors in dog cerebral arteries. Naunyn Schmiedebergs Arch Pharmacol 1986;334:436-43.
5. 2-adrenoceptors in newborn pigs. J Cereb Blood Flow Metab 1987;7:184-8.
6. Kawai Y, Yokoyama S, Ohhashi T. Time-dependent potentiation of contractile response to norepinephrine in canine isolated cerebral arteries. Can J Physiol Pharmacol 1991;69:1889-95.
7. 2 adrenoceptors dilates the rat middle cerebral artery. Anesthesiology 1996;85:82-90.
8. 2. J Cereb Blood Flow Metab 1986;6:358-65.
9. 1-antagonist on cerebral haemodynamics in severely head injured patients. Acta Anaesthesiol Scand 1995;39:347-51.
10. Ishiyama T, Dohi S, Iida H, et al. Mechanisms of dexmedetomidine-induced cerebrovascular effects in canine in vivo experiments. Anesth Analg 1995;81:1208-15.
11. Ishiyama T, Dohi S, Iida H, et al. Mechanisms of vasodilation of cerebral vessels induced by the potassium channel opener nicorandil in canine in vivo experiments. Stroke 1994;25:1644-50.
12. Ishiyama T, Dohi S, Iida H, Wakanabe Y. The effects of topical and intravenous ropivacaine on canine pial microcirculation. Anesth Analg 1997;85:75-81.
13. 2-adrenoceptor subtypes. Annu Rev Pharmacol Toxicol 1993;33:243-79.
14. 2-adrenoceptor agonists. Prog Med Chem 1986;23:1-39.
15. Faraci FM. Role of endothelium-derived relaxing factor in cerebral circulation: large arteries vs. microcirculation. Am J Physiol 1991;261:H1038-42.
16. Nishikawa T, Kirsch JR, Koehler RC, et al. Effect of nitric oxide synthase inhibition on cerebral blood flow and injury volume during focal ischemia in cats. Stroke 1993;24:1717-24.
17. Eglème C, Godfraind T, Miller RC. Enhanced responsiveness of rat isolated aorta to clonidine after removal of the endothelial cells. Br J Pharmacol 1984;81:16-8.
18. Usui H, Fujiwara M, Tsukahara T, et al. Differences in contractile responses to electrical stimulation and α-adrenergic binding sites in isolated cerebral arteries of humans, cows, dogs, and monkeys. J Cardiovasc Pharmacol 1985;7:S47-52.
19. 2-adrenoceptor agonist. Eur J Pharmacol 1988;150:9-14.
20. Taittonen MT, Kirvelä OA, Aantaa R, Kanto JH. Effect of clonidine and dexmedetomidine premedication on perioperative oxygen consumption and haemodynamic state. Br J Anaesth 1997;78:400-6.
21. Greene CS, Gretler DD, Cervenka K, et al. Cerebral blood flow during the acute therapy of severe hypertension with oral clonidine. Am J Emerg Med 1990;8:293-6.
22. 2-adrenergic agonist, decreases cerebral blood flow in the isoflurane-anesthetized dog. Anesth Analg 1990;70:624-30.
23. 2-agonist, on cerebral blood flow and oxygen consumption during halothane anesthesia in dogs. Anesth Analg 1990;71:125-9.
24. 2-adrenergic-mediated cerebral vasoconstriction. Anesth Analg 1994;78:67-72.
25. Hoffman WE, Cheng MA, Thomas C, et al. Clonidine decreases plasma catecholamines and improves outcome from incomplete ischemia in the rat. Anesth Analg 1991;73:460-4.
26. Payen D, Quintin L, Plaisance P, et al. Head injury: clonidine decreases plasma catecholamines. Crit Care Med 1990;18:392-5.
27. Levasseur JE, Kontos HA. Effects of anesthesia on cerebral arteriolar responses to hypercapnia. Am J Physiol 1989;257: H85-8.
28. Hatano Y, Nakamura K, Moriyama S, et al. The contractile responses of isolated dog cerebral and extracerebral arteries to oxybarbiturates and thiobarbiturates. Anesthesiology 1989;71: 80-6.
29. 2-Adrenergic agonist effects on normocapnic and hypercapnic cerebral blood flow in the dog are anesthetic dependent. Anesth Analg 1994;79:892-8.
30. Thomas GP, Krishnamurthy A, Thapar GS, Varma RK. St-93 hyperglycemia in Wistar rats. Arch Int Pharmacodyn Ther 1992; 315:79-86.
31. 2-adrenoceptors in glucoregulation. Brain Res 1991;562:225-9.
32. 2-adrenoceptor antagonist on glucose tolerance in the genetically obese mouse (C57BL/6J ob/ob). Metabolism 1990;39: 445-51.
33. + channels in pancreatic β cells. Br J Pharmacol 1992;107:8-14.
34. Reverte M, García-Barrado MJ, Moratinos J. Role of α-adrenoceptors in control of plasma potassium in conscious rabbits. J Auton Pharmacol 1991;11:305-13.